Hypofractionated Radiotherapy Appropriate for Low-Risk Prostate Cancer Hypofractionated Radiotherapy Appropriate for Low-Risk Prostate Cancer

Hypofractionated radiotherapy (HRT) should be a new practice standard for men with low-risk prostate cancer, based on a secondary analysis of a phase III trial.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news